- Home
- MAT vs NUVL Comparison
MAT vs NUVL Comparison
Compare MAT & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAT
- NUVL
- Stock Information
- Founded
- MAT 1945
- NUVL 2017
- Country
- MAT United States
- NUVL United States
- Employees
- MAT N/A
- NUVL N/A
- Industry
- MAT Recreational Games/Products/Toys
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- MAT Consumer Discretionary
- NUVL Health Care
- Exchange
- MAT Nasdaq
- NUVL Nasdaq
- Market Cap
- MAT 6.5B
- NUVL 7.1B
- IPO Year
- MAT N/A
- NUVL 2021
- Fundamental
- Price
- MAT $21.33
- NUVL $109.00
- Analyst Decision
- MAT Strong Buy
- NUVL Strong Buy
- Analyst Count
- MAT 8
- NUVL 14
- Target Price
- MAT $24.00
- NUVL $134.29
- AVG Volume (30 Days)
- MAT 3.7M
- NUVL 780.8K
- Earning Date
- MAT 10-21-2025
- NUVL 10-30-2025
- Dividend Yield
- MAT N/A
- NUVL N/A
- EPS Growth
- MAT N/A
- NUVL N/A
- EPS
- MAT 1.32
- NUVL N/A
- Revenue
- MAT $5,227,568,000.00
- NUVL N/A
- Revenue This Year
- MAT $1.90
- NUVL N/A
- Revenue Next Year
- MAT $3.34
- NUVL N/A
- P/E Ratio
- MAT $16.04
- NUVL N/A
- Revenue Growth
- MAT N/A
- NUVL N/A
- 52 Week Low
- MAT $13.95
- NUVL $55.54
- 52 Week High
- MAT $22.07
- NUVL $112.88
- Technical
- Relative Strength Index (RSI)
- MAT 72.49
- NUVL 63.92
- Support Level
- MAT $18.32
- NUVL $106.02
- Resistance Level
- MAT $19.76
- NUVL $112.11
- Average True Range (ATR)
- MAT 0.54
- NUVL 5.59
- MACD
- MAT 0.19
- NUVL 0.80
- Stochastic Oscillator
- MAT 95.37
- NUVL 82.28
About MAT Mattel Inc.
Mattel manufactures and markets toy products that are sold to its wholesale and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2024, with the remainder stemming from international markets.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.